Table 2.
Patients with COVID-19 (n = 123) |
||||||
---|---|---|---|---|---|---|
Ambulatory (n = 44) | Moderate (n = 57) | Severe (n = 19) | All (n = 123) | Controls (n = 94) | All (n = 217) | |
Sex | ||||||
Female (%) | 27 (61%) | 25 (44%) | 7 (37%) | 59 (48%) | 60 (64%) | 119 (55%) |
Male (%) | 17 (39%) | 30 (53%) | 12 (63%) | 62 (50%) | 34 (36%) | 96 (44%) |
Missing (%) | NA | 2 (3%) | NA | 2 (2%) | NA | 2 (1%) |
Age | ||||||
Mean (SD) | 47 (14) | 65 (14) | 69 (17) | 59 (17) | 33 (12) | 47 (20) |
Median [Min-Max] | 48 [18 - 71] | 65 [28 - 91] | 76 [32 - 88] | 59 [18 - 91] | 29 [17 - 67] | 45 [17 - 91] |
SARS-CoV-2 genome sequenced (%) | 3 (7%) | 16* (28%) | 7* (35%) | 26 (21%) | NA | NA |
SD = standard deviation. * Including one patient who was not SNP-genotyped because no blood sample was available